http://bostonbiotechwatch.com/2010/03/12/genetix-pharmaceuticals-a-gene-therapy-company-takes-down-35-million-in-a-compelling-turnaround-story/2010-03-12T13:56:23+00:00monthlyhttp://bostonbiotechwatch.com/2010/02/10/domain-sheds-the-vc-blues/2010-02-10T15:28:23+00:00monthlyhttp://bostonbiotechwatch.com/2009/12/21/medicine-gets-personal-but-how-do-vcs-make-money/2010-02-05T15:26:39+00:00monthlyhttp://bostonbiotechwatch.com/2010/01/18/networking-your-medication/2010-01-18T23:24:27+00:00monthlyhttp://bostonbiotechwatch.com/2009/10/26/clouds-over-the-vc-sky/2010-01-15T08:00:04+00:00monthlyhttp://bostonbiotechwatch.com/2009/11/16/what-roche-is-shopping-for-%e2%80%93-and-why-it%e2%80%99s-shopping-in-israel/2009-11-16T17:51:36+00:00monthlyhttp://bostonbiotechwatch.com/2009/10/05/coming-soon-to-a-pharma-near-you-complex-tissue-culture-models/2009-11-12T22:52:22+00:00monthlyhttp://bostonbiotechwatch.com/about/2009-10-20T19:59:39+00:00weekly0.6http://bostonbiotechwatch.com/2009/10/15/17/2009-10-16T04:15:15+00:00monthlyhttp://bostonbiotechwatch.com/daily1.02010-03-12T13:56:23+00:00